Counterpoint Mutual Funds
TXG icon

Counterpoint Mutual Funds’s 10x Genomics TXG Stock Holding History

Counterpoint Mutual Funds’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.4M Buy
+125,769
New +$7.36M 0.98% 8
2025
Q4 		– Sell
-71,398
Closed -$835K – 492
2025
Q3 		$835K Sell
71,398
-6,851
-9% -$89.3K 0.07% 74
2025
Q2 		$906K Sell
78,249
-274
-0.3% -$2.5K 0.08% 57
2025
Q1 		$686K Buy
78,523
+26,865
+52% +$339K 0.1% 121
2024
Q4 		$742K Buy
+51,658
New +$815K 0.09% 74
2024
Q3 		– Sell
-10,861
Closed -$211K – 377
2024
Q2 		$211K Buy
+10,861
New +$284K 0.05% 176
2023
Q4 		– Sell
-5,177
Closed -$214K – 292
2023
Q3 		$214K Buy
5,177
+3,323
+179% +$173K 0.18% 54
2023
Q2 		$104K Buy
+1,854
New +$100K 0.1% 229

Other funds holding TXG

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Convergence Investment Partners
Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return
Cookson Peirce & Co
Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
MIC
Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Counterpoint Mutual Funds's TXG Position: Q3 2026 in Review

Counterpoint Mutual Funds opened a new position in 10x Genomics (TXG) in Q3 2026: 125,769 shares worth $11.4M. The stake represents 0.98% of the portfolio and ranks #8 among its holdings. This is a return to the name: Counterpoint Mutual Funds previously reported a position in TXG as recently as Q3 2025.

Counterpoint Mutual Funds first reported a position in TXG in Q2 2023 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Counterpoint Mutual Funds held 125,769 shares of 10x Genomics worth $11.4M as of Q3 2026.
  • 10x Genomics was a new Counterpoint Mutual Funds position in Q3 2026.
  • 10x Genomics made up 0.98% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #8 holding.
  • Counterpoint Mutual Funds first reported a position in 10x Genomics in Q2 2023 and has held it in 8 quarters since.
  • 126 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.